Compare Shandong Xinhua Pharmaceutical Co., Ltd. with Similar Stocks
Dashboard
1
High Debt company with Weak Long Term Fundamental Strength
- Poor long term growth as Operating profit has grown by an annual rate -7.39% of over the last 5 years
- The company is Net-Debt Free
2
With ROE of 4.96%, it has a Very Expensive valuation with a 0.18 Price to Book Value
3
Underperformed the market in the last 1 year
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-5.79%
0%
-5.79%
6 Months
-12.75%
0%
-12.75%
1 Year
-32.89%
0%
-32.89%
2 Years
14.89%
0%
14.89%
3 Years
4.15%
0%
4.15%
4 Years
-2.9%
0%
-2.9%
5 Years
53.96%
0%
53.96%
Shandong Xinhua Pharmaceutical Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.70%
EBIT Growth (5y)
-7.39%
EBIT to Interest (avg)
10.03
Debt to EBITDA (avg)
1.00
Net Debt to Equity (avg)
0.18
Sales to Capital Employed (avg)
1.22
Tax Ratio
18.43%
Dividend Payout Ratio
37.82%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.33%
ROE (avg)
10.46%
Valuation key factors
Factor
Value
P/E Ratio
4
Industry P/E
Price to Book Value
0.18
EV to EBIT
4.95
EV to EBITDA
2.13
EV to Capital Employed
0.27
EV to Sales
0.19
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.44%
ROE (Latest)
4.96%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bearish
Mildly Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Mar'26 - QoQ
Mar'26
Dec'25
Change(%)
Net Sales
2,734.20
2,185.20
25.12%
Operating Profit (PBDIT) excl Other Income
140.40
230.40
-39.06%
Interest
9.50
15.00
-36.67%
Exceptional Items
0.00
0.00
Consolidate Net Profit
94.00
43.20
117.59%
Operating Profit Margin (Excl OI)
51.40%
28.20%
2.32%
USD in Million.
Net Sales
QoQ Growth in quarter ended Mar 2026 is 25.12% vs -5.84% in Dec 2025
Consolidated Net Profit
QoQ Growth in quarter ended Mar 2026 is 117.59% vs 10.49% in Dec 2025
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
9,462.90
9,178.90
3.09%
Operating Profit (PBDIT) excl Other Income
1,030.50
1,144.20
-9.94%
Interest
48.20
45.90
5.01%
Exceptional Items
3.30
-0.10
3,400.00%
Consolidate Net Profit
332.20
527.70
-37.05%
Operating Profit Margin (Excl OI)
41.10%
60.20%
-1.91%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 3.09% vs 3.72% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is -37.05% vs -5.63% in Dec 2024
About Shandong Xinhua Pharmaceutical Co., Ltd. 
Shandong Xinhua Pharmaceutical Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






